MNBTD
AMRX icon

Moody National Bank Trust Division’s Amneal Pharmaceuticals AMRX Stock Holding History

Moody National Bank Trust Division’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-199
Closed -$3K – 392
2019
Q1 		$3K Buy
+199
New +$2.63K ﹤0.01% 1119

Other funds holding AMRX

FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Moody National Bank Trust Division's AMRX Position: Q2 2019 in Review

Moody National Bank Trust Division sold out of Amneal Pharmaceuticals (AMRX) in Q2 2019, closing a stake of 199 shares — an estimated $3K sold.

Moody National Bank Trust Division first reported a position in AMRX in Q1 2019 and held it in 1 quarter. The position peaked at $3K in Q1 2019. 129 funds tracked by Wall St. Rank hold AMRX as of Q2 2019.

  • Moody National Bank Trust Division reported no remaining Amneal Pharmaceuticals position as of Q2 2019 after selling out during the quarter.
  • Moody National Bank Trust Division sold 199 Amneal Pharmaceuticals shares in Q2 2019, an estimated $3K.
  • Moody National Bank Trust Division first reported a position in Amneal Pharmaceuticals in Q1 2019 and held it in 1 quarter.
  • Moody National Bank Trust Division's Amneal Pharmaceuticals position peaked at $3K in Q1 2019.
  • 129 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2019.

Based on Moody National Bank Trust Division's 13F filing for Q2 2019, filed 22 Jul 2019.